A detailed history of Boyar Asset Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Boyar Asset Management Inc. holds 5,361 shares of MRK stock, worth $536,421. This represents 0.41% of its overall portfolio holdings.

Number of Shares
5,361
Previous 4,426 21.13%
Holding current value
$536,421
Previous $547,000 11.15%
% of portfolio
0.41%
Previous 0.39%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 22, 2024

BUY
$111.15 - $128.97 $103,925 - $120,586
935 Added 21.13%
5,361 $608,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $1,903 - $2,071
19 Added 0.43%
4,426 $482,000
Q3 2023

Nov 07, 2023

SELL
$102.95 - $114.33 $514 - $571
-5 Reduced 0.11%
4,407 $453,000
Q2 2023

Jul 26, 2023

SELL
$108.61 - $118.38 $4,887 - $5,327
-45 Reduced 1.01%
4,412 $509,000
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $161,718 - $180,445
-1,571 Reduced 26.06%
4,457 $474,000
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $418,138 - $536,110
-4,782 Reduced 44.24%
6,028 $668,000
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $264,325 - $296,939
3,127 Added 40.7%
10,810 $931,000
Q2 2022

Aug 08, 2022

SELL
$83.49 - $94.64 $22,124 - $25,079
-265 Reduced 3.33%
7,683 $700,000
Q1 2022

Apr 27, 2022

BUY
$73.51 - $82.4 $14,702 - $16,480
200 Added 2.58%
7,948 $652,000
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $89,265 - $111,816
1,235 Added 18.96%
7,748 $594,000
Q3 2021

Oct 18, 2021

BUY
$71.68 - $78.83 $39,639 - $43,592
553 Added 9.28%
6,513 $489,000
Q2 2021

Aug 04, 2021

BUY
$70.31 - $77.77 $167,689 - $185,481
2,385 Added 66.71%
5,960 $464,000
Q1 2021

May 04, 2021

BUY
$68.86 - $81.11 $246,174 - $289,968
3,575 New
3,575 $276,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Boyar Asset Management Inc. Portfolio

Follow Boyar Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boyar Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Boyar Asset Management Inc. with notifications on news.